Skye Bioscience, Inc.
Pharmaceutical company · San Diego, California, United States · Nasdaq: SKYE
Skye Bioscience, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker SKYE. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2024.
Skye Bioscience at a glance
What does Skye Bioscience do?
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $40 million sold (2024).
Frequently asked questions about Skye Bioscience
Where is Skye Bioscience headquartered?
Skye Bioscience, Inc. is headquartered in San Diego, California, United States.
What does Skye Bioscience do?
Skye Bioscience, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Skye Bioscience a public company?
Yes. Skye Bioscience, Inc. trades on Nasdaq under the ticker SKYE.
When was Skye Bioscience founded?
The earliest incorporation on record for Skye Bioscience, Inc. is in 2011, according to public company registers.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Avidity Biosciences, Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.